Sponsor Pipeline

Paradigm Therapeutics Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
1
Recruiting
2
Phase 3
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-07-24 NCT07482787
Efficacy and Safety Study to Evaluate SD-101 in Epidermolysis Bullosa		 Recruitment opened
Active Trials by Phase
Phase 3
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07482787 Efficacy and Safety Study to Evaluate SD-101 in Epidermolysis Bullosa Epidermolysis Bullosa (EB) Recruiting
NCT07482813 An Open Label Extension Safety Study to Evaluate SD-101 in Epidermolysis Bullosa Epidermolysis Bullosa (EB) Not Yet Recruiting
Get alerts when Paradigm Therapeutics's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free